The Athlete Biological Passport

Author:

Sottas Pierre-Edouard1,Robinson Neil1,Rabin Olivier2,Saugy Martial1

Affiliation:

1. Swiss Laboratory for Anti-Doping Analyses, Chemin des Croisettes, 1066 Lausanne, Switzerland

2. World Anti-Doping Agency, Montreal, Canada

Abstract

BACKGROUND In elite sports, the growing availability of doping substances identical to those naturally produced by the human body seriously limits the ability of drug-testing regimes to ensure fairness and protection of health. CONTENT The Athlete Biological Passport (ABP), the new paradigm in testing based on the personalized monitoring of biomarkers of doping, offers the enormous advantage of being independent of this endless pharmaceutical race. Doping triggers physiological changes that provide physiological enhancements. In the same way that disease-related biomarkers are invaluable tools that assist physicians in the diagnosis of pathology, specifically selected biomarkers can be used to detect doping. SUMMARY The ABP is a new testing paradigm with immense potential value in the current climate of rapid advancement in biomarker discovery. In addition to its original aim of providing proof of a doping offense, the ABP can also serve as a platform for a Rule of Sport, with the presentation before competition of the ABP to objectively demonstrate that the athlete will participate in a healthy physiological condition that is unaltered by performance-enhancing drugs. Finally, the decision-support system used today for the biological monitoring of world top-level athletes can also be advantageously transferred to other areas of clinical practice to reach the goal of personalized medicine.

Publisher

Oxford University Press (OUP)

Subject

Biochemistry (medical),Clinical Biochemistry

Reference33 articles.

1. WADA. World anti-doping code 2009. www.wada-ama.org/rtecontent/document/code_v2009_En.pdf (Accessed May 2011).

2. Mass spectrometry in sports drug testing: structure characterization and analytical assays;Thevis;Mass Spectrom Rev,2010

3. Current and upcoming erythropoiesis-stimulating agents, iron products, and other novel anemia medications;Macdougall;Adv Chronic Kidney Dis,2009

4. Nachweis von exogenem Testosterone;Donike,1983

5. Evaluating an abnormal urinary steroid profile;Oftebro;Lancet,1992

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3